Navigation Links
USPTO Issues Patent for CardioGenics' Signal Amplification Technology
Date:6/29/2011

MISSISSAUGA, Ontario, June 29, 2011 /PRNewswire/ -- CardioGenics Holdings Inc. (CGNH.OB) announced today that the United States Patent & Trademark Office (USPTO) has notified the company that its patent application has been granted (issued patent # 7,964,415). This patent covers CardioGenics Inc.'s proprietary signal amplification technology, which is a key component of the core technology for CardioGenics' Ultra-Sensitive QL Care™ Analyzer. CardioGenics' unique methodology for signal amplification enables a decrease in the amount of binding reagents used in immunoassay diagnostic tests, such as those to be performed on the QL Care™ Analyzer, which, in turn, results in improved signal-to-noise ratio thereby increasing testing sensitivity.

"We are very pleased that the USPTO has recognized the unique nature of CardioGenics' signal amplification technology," said Dr. Yahia Gawad, CEO of CardioGenics. "This patent is an important addition to our patent portfolio since it addresses a key component of the technology that permits the ultra-sensitive performance of our QL Care™ Analyzer," continued Dr. Gawad.

About CardioGenics Holdings Inc.

Through its operating subsidiaries, the Company develops ultra-sensitive analyzers and other products targeting the immunoassay segment of the Point-Of-Care IVD testing market. It has developed the QL Care™ Analyzer, a proprietary and ultra-sensitive Point-Of-Care immuno-analyzer, which will run a number of diagnostic tests under development, the first of which will be a series of cardiovascular diagnostic tests. As part of its core proprietary technology, the Company has also developed a proprietary method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improve instrument sensitivity to light. The Company's proprietary microspheres technology and SAVAsphere magnetic beads are developed and marketed through the Company's Luxspheres subsidiary. The Company's principal offices are located in Mississauga, Ontario, Canada. For more information please visit www.cardiogenics.com and www.luxspheres.com.

Safe Harbor Statement - Certain statements made herein that are not historical are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements, with words such as "anticipate, "believe," "expect," "future," "may," "will," "should," "plan," "projected," "intend," and similar expressions to identify forward-looking statements. These statements are based on the Company's beliefs and the assumptions it made using information currently available to it. Because these statements reflect the Company's current views concerning future events, these statements involve risks, uncertainties and assumptions. The actual results could differ materially from the results discussed in the forward-looking statements. In any event, undue reliance should not be placed on any forward-looking statements, which apply only as of the date of this press release. Accordingly, reference should be made to the Company's periodic filings with the Securities and Exchange Commission.


'/>"/>
SOURCE CardioGenics Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shrink Nanotechnologies Announces That Critical Cell Align Tissue Engineering Platform Patent as Well as IP on a Novel Immunoassay Substrate Material Has Been Filed With the USPTO
2. USPTO Allows NivaSonix Core Patent - External Ultrasound Lipoplasty
3. KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Companys ADHD Prodrug Technology
4. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
5. Endo Pharmaceuticals Issues Voluntary, Nationwide Recall of Two Lots of Endocet® (Oxycodone/Acetaminophen, USP) Tablets, 10 Mg /325 Mg
6. Preliminary Results of a Large Scale Study Show ConvaTec Moldable Technology™ Skin Barriers Help to Prevent and Improve Peristomal Skin Issues in Ostomy Patients
7. Health Information Technology: UC San Diego New Seminar Explores Four Critical Issues
8. FDA Issues Draft Guidance for Early Version of an Artificial Pancreas System
9. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
10. United Kingdoms National Institute for Health and Clinical Excellence Issues Guidance on Percutaneous Tibial Nerve Stimulation for Faecal Incontinence
11. BD Issues 2010 Sustainability Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... PROVO, Utah , May 3, 2016  Forté Elements, LLC (Forté) is excited ... use nutritional products that address the nutritional needs of recovery for a variety of ... its products. Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)... YORK , May 2, 2016 Leading Economies with ... Ethiopia 10.2 Côte d,Ivoire 8.6 Uzbekistan 8 Ireland 7.8 India 7.3, ... Research, BRICS nations , which comprises of Brazil , ... and South Africa , registered the fastest GDP ... slowdown in China , recession in Brazil ...
(Date:5/2/2016)... The global  ultrasound device ... by 2024, according to a new report published ... the sonography market include expanding applications of the ... periodic ultrasound screenings of the breast for breast ... ) High Intensity Focused Ultrasound (HIFU) ...
Breaking Medicine Technology:
(Date:5/3/2016)... ... ... Huntington Beach orthopedic doctor , Dr. Rick Pospisil, now offers arthroscopic ... diagnose and treat joint problems. During this procedure, Dr. Pospisil makes a small incision ... and lens that illuminate and magnify the various structures in the joint so that ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... today announced the new SecureAccess feature for its CelestixEdge solution. CelestixEdge is ... will enable organizations to get the DirectAccess user experience on unsupported DirectAccess ...
(Date:5/3/2016)... Bethesda, MD (PRWEB) , ... May 03, 2016 , ... ... new line of reusable bags to replace billions of single-use, throw away plastic baggies. ... waste devastating our oceans and sea life. , “The LunchSkins mission is ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... the state-of-the-art Carnival Vista – the line’s largest cruise ship ever. To ... has created an infographic spotlighting the Carnival Vista ’s most exciting ...
(Date:5/2/2016)... , ... May 02, 2016 , ... It has just ... the keynote speaker for five events throughout the month of May. , Uldrich is ... of national news outlets. He also frequently appears on the Science Channel’s FutureScape and ...
Breaking Medicine News(10 mins):